Boulder biotech Biodesix CEO: Why timing was right for IPO

In an exclusive interview, CEO Scott Hutton talks about the next steps for the company, which specializes in blood-based diagnostic tests for lung diseases.

Find out more in the Denver Business Journal article.

Categories: Ecosystem News